Showing results (1141-1150 of 2,572) with videos related to

Sort By:
Pageof 258
Annals of Emergency Medicine|January 28, 2003
Intervention to decrease emergency department crowding: does it have an effect on return visits and hospital readmissions?Sylvie Cardin, Marc Afilalo, Eddy Lang, et al.
Annals of Neurology|June 1, 1992
3-O-methyldopa administration does not alter fluorodopa transport into the brainM Guttman, G Léger, J M Cedarbaum, et al.
Journal of Pediatric Surgery|September 1, 1994
Gastroesophageal reflux associated with large diaphragmatic herniasD L Sigalet, L T Nguyen, V Adolph, et al.
Journal of Pediatric Surgery|February 1, 1995
Repair of congenital diaphragmatic hernia after weaning from extracorporeal membrane oxygenationV Adolph, H Flageole, T Perreault, et al.
Science (New York, N.Y.)|March 2, 2002
A functional screen for the type III (Hrp) secretome of the plant pathogen Pseudomonas syringaeDavid S Guttman, Boris A Vinatzer, Sara F Sarkar, et al.
Computers in Biology and Medicine|January 28, 2025
Predicting the effectiveness of chemotherapy treatment in lung cancer utilizing artificial intelligence-supported serum N-glycome analysisRebeka Torok, Brigitta Meszaros, Veronika Gombas, et al.
Journal of the International Neuropsychological Society : JINS|September 20, 2006
Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS)Ralph H B Benedict, Diane Cookfair, Rebecca Gavett, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 21, 2012
Effectiveness of multidisciplinary care for Parkinson's disease: a randomized, controlled trialMarjolein A van der Marck, Bastiaan R Bloem, George F Borm, et al.
Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology|December 2, 2020
Differential Diagnosis of Cognitive Decline in Elderly Individuals With Multiple SclerosisDejan Jakimovski, Kinga Szigeti, Michael Jaworski, et al.
Journal of Drugs in Dermatology : JDD|April 7, 2016
Crisaborole Topical Ointment, 2%: A Nonsteroidal, Topical, Anti-Inflammatory Phosphodiesterase 4 Inhibitor in Clinical Development for the Treatment of Atopic DermatitisKurt Jarnagin, Sanjay Chanda, Dina Coronado, et al.
Pageof 258